Annual Cash & Cash Equivalents
$150.00 M
+$23.00 M+18.11%
December 31, 2024
Summary
- As of March 12, 2025, RCUS annual cash & cash equivalents is $150.00 million, with the most recent change of +$23.00 million (+18.11%) on December 31, 2024.
- During the last 3 years, RCUS annual cash & cash equivalents has risen by +$2.00 million (+1.35%).
- RCUS annual cash & cash equivalents is now -27.18% below its all-time high of $206.00 million, reached on December 31, 2022.
Performance
RCUS Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$150.00 M
-$51.00 M-25.37%
December 31, 2024
Summary
- As of March 12, 2025, RCUS quarterly cash and cash equivalents is $150.00 million, with the most recent change of -$51.00 million (-25.37%) on December 31, 2024.
- Over the past year, RCUS quarterly cash and cash equivalents has increased by +$23.00 million (+18.11%).
- RCUS quarterly cash and cash equivalents is now -72.67% below its all-time high of $548.78 million, reached on March 31, 2022.
Performance
RCUS Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
RCUS Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +18.1% | +18.1% |
| 3 y3 years | +1.4% | +1.4% |
| 5 y5 years | +158.9% | +158.9% |
RCUS Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -27.2% | +18.1% | -72.7% | +18.1% |
| 5 y | 5-year | -27.2% | +158.9% | -72.7% | +158.9% |
| alltime | all time | -27.2% | +158.9% | -72.7% | +158.9% |
Arcus Biosciences Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $150.00 M(+18.1%) | $150.00 M(-25.4%) |
| Sep 2024 | - | $201.00 M(+28.8%) |
| Jun 2024 | - | $156.00 M(-15.7%) |
| Mar 2024 | - | $185.00 M(+45.7%) |
| Dec 2023 | $127.00 M(-38.3%) | $127.00 M(-31.0%) |
| Sep 2023 | - | $184.00 M(-20.0%) |
| Jun 2023 | - | $230.00 M(-3.4%) |
| Mar 2023 | - | $238.00 M(+15.5%) |
| Dec 2022 | $206.00 M(+39.2%) | $206.00 M(-5.4%) |
| Sep 2022 | - | $217.65 M(-20.2%) |
| Jun 2022 | - | $272.63 M(-50.3%) |
| Mar 2022 | - | $548.78 M(+270.8%) |
| Dec 2021 | $148.00 M | $148.00 M(-17.5%) |
| Sep 2021 | - | $179.43 M(-44.0%) |
| Jun 2021 | - | $320.48 M(-17.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | $390.26 M(+125.0%) |
| Dec 2020 | $173.41 M(+199.3%) | $173.41 M(-21.8%) |
| Sep 2020 | - | $221.85 M(-22.2%) |
| Jun 2020 | - | $285.19 M(+323.6%) |
| Mar 2020 | - | $67.33 M(+16.2%) |
| Dec 2019 | $57.94 M(-18.5%) | $57.94 M(-26.7%) |
| Sep 2019 | - | $78.99 M(+3.8%) |
| Jun 2019 | - | $76.07 M(+11.0%) |
| Mar 2019 | - | $68.50 M(-3.6%) |
| Dec 2018 | $71.06 M(-27.8%) | $71.06 M(-5.1%) |
| Sep 2018 | - | $74.89 M(-55.9%) |
| Jun 2018 | - | $170.00 M(-14.2%) |
| Mar 2018 | - | $198.12 M(+101.3%) |
| Dec 2017 | $98.43 M(+51.1%) | $98.43 M |
| Dec 2016 | $65.16 M | - |
FAQ
- What is Arcus Biosciences annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Arcus Biosciences?
- What is Arcus Biosciences annual cash & cash equivalents year-on-year change?
- What is Arcus Biosciences quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Arcus Biosciences?
- What is Arcus Biosciences quarterly cash and cash equivalents year-on-year change?
What is Arcus Biosciences annual cash & cash equivalents?
The current annual cash & cash equivalents of RCUS is $150.00 M
What is the all time high annual cash & cash equivalents for Arcus Biosciences?
Arcus Biosciences all-time high annual cash & cash equivalents is $206.00 M
What is Arcus Biosciences annual cash & cash equivalents year-on-year change?
Over the past year, RCUS annual cash & cash equivalents has changed by +$23.00 M (+18.11%)
What is Arcus Biosciences quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of RCUS is $150.00 M
What is the all time high quarterly cash and cash equivalents for Arcus Biosciences?
Arcus Biosciences all-time high quarterly cash and cash equivalents is $548.78 M
What is Arcus Biosciences quarterly cash and cash equivalents year-on-year change?
Over the past year, RCUS quarterly cash and cash equivalents has changed by +$23.00 M (+18.11%)